Cidofovir in Severe Hypoxemic Adenoviral Pneumonia

Aditi Gupta1, Pooja Khanna1, Arjun Parihar1

  • 1Department of Pediatrics, Amrita Hospital, Mata Amritanandamayi Marg, Sector 88, Faridabad, Haryana, 121002, India.

PubMed

Insights

A severe adenovirus pneumonia case in a 16-month-old boy, unresponsive to supportive care, rapidly improved with intravenous cidofovir. This highlights cidofovir as a potential treatment for severe adenovirus infections.

Area of Science:

  • Pediatric Infectious Diseases
  • Virology
  • Critical Care Medicine

Background:

  • Adenovirus infections can cause severe pneumonia in young children.
  • Hypoxemic pneumonia necessitates prompt and effective therapeutic interventions.

Purpose of the Study:

  • To report a case of severe adenovirus pneumonia in an infant.
  • To evaluate the efficacy of intravenous cidofovir in treating severe adenovirus pneumonia.

Main Methods:

  • Clinical case presentation of a 16-month-old boy with severe hypoxemic pneumonia.
  • Diagnostic confirmation of adenovirus via nasopharyngeal aspirate.
  • Administration of intravenous cidofovir for treatment.

Main Results:

  • The patient presented with flu-like symptoms and progressed to severe hypoxemic pneumonia.
  • Adenovirus was identified as the causative pathogen.
  • Intravenous cidofovir administration led to rapid clinical improvement.

Conclusions:

  • Intravenous cidofovir demonstrated significant efficacy in treating severe adenovirus pneumonia in an infant.
  • Cidofovir represents a promising therapeutic option for severe, refractory adenovirus infections in pediatric patients.

Related Concept Videos

Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
176
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
263
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
359
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
272
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
162
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
223